- Home
- CATO vs RENB Comparison
CATO vs RENB Comparison
Compare CATO & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATO
- RENB
- Stock Information
- Founded
- CATO 1946
- RENB 2011
- Country
- CATO United States
- RENB United States
- Employees
- CATO N/A
- RENB N/A
- Industry
- CATO Clothing/Shoe/Accessory Stores
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- CATO Consumer Discretionary
- RENB Health Care
- Exchange
- CATO Nasdaq
- RENB Nasdaq
- Market Cap
- CATO 59.2M
- RENB 62.0M
- IPO Year
- CATO N/A
- RENB N/A
- Fundamental
- Price
- CATO $2.85
- RENB $0.28
- Analyst Decision
- CATO
- RENB
- Analyst Count
- CATO 0
- RENB 0
- Target Price
- CATO N/A
- RENB N/A
- AVG Volume (30 Days)
- CATO 41.5K
- RENB 8.2M
- Earning Date
- CATO 08-21-2025
- RENB 05-15-2025
- Dividend Yield
- CATO 6.06%
- RENB N/A
- EPS Growth
- CATO N/A
- RENB N/A
- EPS
- CATO N/A
- RENB N/A
- Revenue
- CATO $642,949,000.00
- RENB N/A
- Revenue This Year
- CATO N/A
- RENB N/A
- Revenue Next Year
- CATO N/A
- RENB N/A
- P/E Ratio
- CATO N/A
- RENB N/A
- Revenue Growth
- CATO N/A
- RENB N/A
- 52 Week Low
- CATO $2.19
- RENB $0.27
- 52 Week High
- CATO $6.70
- RENB $2.10
- Technical
- Relative Strength Index (RSI)
- CATO 52.16
- RENB 37.30
- Support Level
- CATO $2.71
- RENB $0.33
- Resistance Level
- CATO $2.99
- RENB $0.37
- Average True Range (ATR)
- CATO 0.21
- RENB 0.04
- MACD
- CATO -0.02
- RENB -0.01
- Stochastic Oscillator
- CATO 25.64
- RENB 2.70
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.